The endocannabinoid system in the amygdala and modulation of fear.

作者: Ozge Gunduz-Cinar

DOI: 10.1016/J.PNPBP.2020.110116

关键词:

摘要: Posttraumatic stress disorder (PTSD) is a persistent, trauma induced psychiatric condition characterized by lifelong complex cognitive, emotional and behavioral phenotype. Although many individuals that experience are able to gradually diminish their responding trauma-related stimuli over time, known as extinction learning, suffering from PTSD impaired in this capacity. An inability decline initially normal adaptive fear response, can be confronted with exposure-based therapies, often combination pharmacological treatments. Due the complexity of PTSD, currently available pharmacotherapeutics inadequate treating deficient observed patients. To develop novel therapeutics, researchers have exploited conserved nature stress-associated responses neurocircuits across species an attempt translate knowledge gained preclinical studies into clinic. There growing evidence on endocannabinoid modulation due 'on demand' synthesis degradation. Involvement endocannabinoids makes system very attractive for finding effective therapeutics related disorders. In review, brief introduction neuroanatomy circuitry will provided model study PTSD. Then, discussed important component modulation. regard, anandamide degrading enzyme, fatty acid amide hydrolase (FAAH) exemplified target identified validated strongly clinical translational enhancing extinction.

参考文章(172)
Michelle Roche, Emer O'Connor, Catherine Diskin, David P. Finn, The effect of CB1 receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats European Journal of Neuroscience. ,vol. 26, pp. 2643- 2653 ,(2007) , 10.1111/J.1460-9568.2007.05861.X
Isabelle Boileau, Rachel F Tyndale, Belinda Williams, Esmaeil Mansouri, Duncan J Westwood, Bernard Le Foll, Pablo M Rusjan, Romina Mizrahi, Vincenzo De Luca, Qian Zhou, Alan A Wilson, Sylvain Houle, Stephen J Kish, Junchao Tong, The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB. Journal of Cerebral Blood Flow and Metabolism. ,vol. 35, pp. 1237- 1240 ,(2015) , 10.1038/JCBFM.2015.119
Istvan Katona, Beata Sperlagh, Attila Sık, Attila Käfalvi, E Sylvester Vizi, Ken Mackie, Tamas F Freund, Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons The Journal of Neuroscience. ,vol. 19, pp. 4544- 4558 ,(1999) , 10.1523/JNEUROSCI.19-11-04544.1999
J M Qualy, A C Howlett, L L Khachatrian, Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Molecular Pharmacology. ,vol. 29, pp. 307- 313 ,(1986)
Sherry Shu-Jung Hu, Ken Mackie, Distribution of the Endocannabinoid System in the Central Nervous System. Handbook of experimental pharmacology. ,vol. 231, pp. 59- 93 ,(2015) , 10.1007/978-3-319-20825-1_3
Ozge Gunduz-Cinar, Shaun Flynn, Emma Brockway, Katherine Kaugars, Rita Baldi, Teniel S Ramikie, Resat Cinar, George Kunos, Sachin Patel, Andrew Holmes, Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids Neuropsychopharmacology. ,vol. 41, pp. 1598- 1609 ,(2016) , 10.1038/NPP.2015.318
Sachin Patel, Craig T. Roelke, David J. Rademacher, Cecilia J. Hillard, Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling European Journal of Neuroscience. ,vol. 21, pp. 1057- 1069 ,(2005) , 10.1111/J.1460-9568.2005.03916.X
W. Twitchell, S. Brown, K. Mackie, Cannabinoids Inhibit N- and P/Q-Type Calcium Channels in Cultured Rat Hippocampal Neurons Journal of Neurophysiology. ,vol. 78, pp. 43- 50 ,(1997) , 10.1152/JN.1997.78.1.43
Sachin Patel, Philip J Kingsley, Ken Mackie, Lawrence J Marnett, Danny G Winder, Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala Neuropsychopharmacology. ,vol. 34, pp. 2699- 2709 ,(2009) , 10.1038/NPP.2009.101